Results per Page:
Foot on the gas: How RIT1 and YAP accelerate lung adenocarcinoma
From the Berger Lab, Human Biology Division
E6 oncoprotein as a biomarker used to triage anal cancer screening
From Faiza Faria, Clinical Research Division in collaboration with the University of Washington School of Public Health Department of Epidemiology
Benign meningiomas can’t stop YAP-ing, but aggressive subtypes are more soft-spoken
From the Holland Lab, Human Biology Division
Stabilization or degradation? A long-standing Myc model amended
From the Clurman Lab, Human Biology & Clinical Research Divisions
Short H2A histones, part II: a natural-born oncogene lurking in our genomes
From the Malik, Henikoff, Bleakley, and Bradley labs, Basic Sciences Division
Researchers identify new way skin stops tumor growth
‘Oncogene-induced differentiation’ joins two other strategies for counteracting potentially cancer-causing DNA changes
Eisenman receives $7M NCI Outstanding Investigator Award
Molecular biologist will continue to seek tumors’ weaknesses by mapping important molecular pathways
Doctor, researcher, patient and pathfinder
Dr. Paul Neiman reflects on 40 years of leadership, collaboration and curiosity
'Orphan drug' used for sleep disorders may be potent cancer fighter
Carla Grandori-led study shows new screening technology, genetic techniques poised to accelerate cancer therapy development by 'a thousand-fold'
Roger Brent and Robert Eisenman named AAAS fellows
Both are researchers in the Hutchinson Center’s Basic Sciences Division